超越低甲基剂:新疗法和有针对性的方法
Viviana Cortiana1, Harshitha Vallabhaneni2, Jenna Ghazal3
1Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126 Bologna, Italy.
Clinical hematology international
|August 11, 2025
概括
骨髓质疏松症候群 (MDS) 是一种克隆性血液疾病,具有有限的高风险治疗方法. 未来的战略重点是精准医学,将基因组学和新疗法结合起来,以获得更好的患者结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 遗传学是一种遗传学.
背景情况:
- 骨髓质综合征 (MDS) 是一种克隆性造血干细胞疾病,其特征是无效的造血,细胞衰竭和转化为急性骨髓性白血病 (AML) 的高风险.
- 目前的分类系统 (ICC,WHO 2022) 整合了分子和细胞遗传标记,用于风险分层和治疗指导.
- 现有的治疗方法,包括低甲基化剂 (HMA),对于高风险MDS (HR-MDS) 提供有限的生存益处.
研究的目的:
- 审查当前和新兴的治疗策略,用于骨髓质疏松综合征 (MDS).
- 突出目前治疗方法的局限性和新药和精准医学方法的潜力.
- 强调需要预测生物标志物来优化针对性治疗和免疫治疗的患者选择.
主要方法:
- 对MDS分类,治疗选择和新兴疗法的当前文献的审查.
- 对免疫检查点抑制剂 (ICI) 和新型向药物的临床试验结果的分析.
- 讨论分子表征和精准医学在未来MDS管理中的作用.
主要成果:
- 免疫检查点抑制剂 (ipilimumab,durvalumab) 在MDS中表现出有限的疗效,表明需要改进患者选择和组合策略.
- 新兴药物如luspatercept和imetelstat在改善输血独立性和血液反应方面对低风险的MDS (LR-MDS) 显示出前景.
- 探索性药物 (pevonedistat,magrolimab,sabatolimab) 正在对HR-MDS进行研究,重点是针对性和免疫调节机制.
结论:
- 治疗MDS的未来在于精密医学,利用分子分析来指导治疗决策.
- 确定预测性生物标志物对于成功应用向疗法和免疫疗法至关重要.
- 结合基因组学,新疗法和免疫调节的综合方法对于推进MDS患者护理至关重要.
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
01:17Phase II Reactions: Methylation Reactions
342
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
342
01:28Drug Therapy
98
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
98
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K